Global Pharmaceutical CDMO Services Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major 40 Countries or Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • The Pharmaceutical CDMO Services is expected to grow from USD XX.0 million in 2018 to USD XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of XX.0% during the forecast period. The research provides insights for the global Pharmaceutical CDMO Services market based on different Types, End-Users and Regions, and competitive landscape of these segments are analyzed in detail.

    A wide range of market influence factors are taken into consideration in the analysis, and potential developing factors for different Types, End-Users and Regions are also included in the report in order to figure out the most promising development trends in the Pharmaceutical CDMO Services industry. For presenting the most potential investment fields in North America, Europe, Asia Pacific and Latin America, Middle East & Africa, the market capacity and consumption potential of more than 34 major powers are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Global Pharmaceutical CDMO Services Market Segmentations:

    By Players:

    • Amatsigroup

    • FAMAR Health Care Services

    • Piramal Pharma Solutions

    • Strides Pharma Science Limited

    • Fareva Group

    • Aenova Group

    • WuXi AppTec Group

    • AMRI Global

    • Siegfried Ltd

    • Patheon NV

    • Recipharm AB

    • Catalent, Inc

    By Types:

    • Drug Substance Development and Manufacturing

    • Specialized Services

    • Lab-based Services

    By End-User:

    • Innovative Medicine

    • Patented Drug

    • Patent Expired Drug

    By Regions:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • France

    • Italy

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

    • Spain

    • Belgium

    • Poland

    • Russia

    • Turkey

    • Others

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Australia and New Zealand

    • ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)

    Latin America, Middle East & Africa

    • GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)

    • Brazil

    • Nigeria

    • South Africa

    • Argentina

    • Others

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Pharmaceutical CDMO Services Market

    • 1.3 Market Segmentation by Type

      • 1.3.1 Global Pharmaceutical CDMO Services Market Size and Growth Rate of Drug Substance Development and Manufacturing from 2014 to 2026

      • 1.3.2 Global Pharmaceutical CDMO Services Market Size and Growth Rate of Specialized Services from 2014 to 2026

      • 1.3.3 Global Pharmaceutical CDMO Services Market Size and Growth Rate of Lab-based Services from 2014 to 2026

    • 1.4 Market Segmentation by End-Users

      • 1.4.1 Global Pharmaceutical CDMO Services Market Size and Growth Rate of Innovative Medicine from 2014 to 2026

      • 1.4.2 Global Pharmaceutical CDMO Services Market Size and Growth Rate of Patented Drug from 2014 to 2026

      • 1.4.3 Global Pharmaceutical CDMO Services Market Size and Growth Rate of Patent Expired Drug from 2014 to 2026

    • 1.5 Market Segmentation by Regions

      • 1.5.1 North America Pharmaceutical CDMO Services Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.1 United States Pharmaceutical CDMO Services Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.2 Canada Pharmaceutical CDMO Services Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.3 Mexico Pharmaceutical CDMO Services Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Europe Pharmaceutical CDMO Services Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.1 Germany Pharmaceutical CDMO Services Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.2 UK Pharmaceutical CDMO Services Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.3 France Pharmaceutical CDMO Services Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.4 Italy Pharmaceutical CDMO Services Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.5 Nordic Countries Pharmaceutical CDMO Services Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.6 Spain Pharmaceutical CDMO Services Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.7 Belgium Pharmaceutical CDMO Services Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.8 Poland Pharmaceutical CDMO Services Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.9 Russia Pharmaceutical CDMO Services Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.10 Turkey Pharmaceutical CDMO Services Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Asia-Pacific Pharmaceutical CDMO Services Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.1 China Pharmaceutical CDMO Services Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.2 Japan Pharmaceutical CDMO Services Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.3 Australia and New Zealand Pharmaceutical CDMO Services Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.4 India Pharmaceutical CDMO Services Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.5 ASEAN Countries Pharmaceutical CDMO Services Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.6 South Korea Pharmaceutical CDMO Services Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Latin America, Middle East & Africa Pharmaceutical CDMO Services Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.1 GCC Countries Pharmaceutical CDMO Services Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.2 Brazil Pharmaceutical CDMO Services Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.3 Nigeria Pharmaceutical CDMO Services Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.4 South Africa Pharmaceutical CDMO Services Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.5 Argentina Pharmaceutical CDMO Services Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints 

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Pharmaceutical CDMO Services Market by Types

    • 3.1 Product Development Trends of Different Types

    • 3.2 Commercial Product Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Pharmaceutical CDMO Services by Major Types

      • 3.4.1 Pharmaceutical CDMO Services Market Size and Growth Rate of Drug Substance Development and Manufacturing

      • 3.4.2 Pharmaceutical CDMO Services Market Size and Growth Rate of Specialized Services

      • 3.4.3 Pharmaceutical CDMO Services Market Size and Growth Rate of Lab-based Services

    4 Segmentation of Pharmaceutical CDMO Services Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Pharmaceutical CDMO Services by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Pharmaceutical CDMO Services in Innovative Medicine

      • 4.4.2 Market Size and Growth Rate of Pharmaceutical CDMO Services in Patented Drug

      • 4.4.3 Market Size and Growth Rate of Pharmaceutical CDMO Services in Patent Expired Drug

    5 Market Analysis by Major Regions

    • 5.1 Global Pharmaceutical CDMO Services Production Analysis by Major Regions

    • 5.2 Global Pharmaceutical CDMO Services Consumption Analysis by Major Regions

    • 5.3 Global Pharmaceutical CDMO Services Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 North America Pharmaceutical CDMO Services Production, Import, Consumption and Export Analysis 

      • 5.3.2 Europe Pharmaceutical CDMO Services Production, Import, Consumption and Export Analysis

      • 5.3.3 Asia Pacific Pharmaceutical CDMO Services Production, Import, Consumption and Export Analysis

      • 5.3.4 Latin America, Middle East & Africa Pharmaceutical CDMO Services Production, Import, Consumption and Export Analysis

    6 Product Commodity of Pharmaceutical CDMO Services Market in Major Countries

    • 6.1 Top 5 Export Countries in Pharmaceutical CDMO Services market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries' Export Value Analysis in Pharmaceutical CDMO Services market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries'  Export Volume Analysis in Pharmaceutical CDMO Services market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Pharmaceutical CDMO Services market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries' Import Value Analysis in Pharmaceutical CDMO Services market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries' Import Volume Analysis in Pharmaceutical CDMO Services market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7 North America Pharmaceutical CDMO Services Landscape Analysis

    • 7.1 North America Pharmaceutical CDMO Services Landscape Analysis by Major Types

    • 7.2 North America Pharmaceutical CDMO Services Landscape Analysis by Major End-Users

    • 7.3 North America Pharmaceutical CDMO Services Landscape Analysis by Major Countries

      • 7.3.1 United States Pharmaceutical CDMO Services Market Volume and Growth Rate

      • 7.3.2 Canada Pharmaceutical CDMO Services Market Volume and Growth Rate

      • 7.3.3 Mexico Pharmaceutical CDMO Services Market Volume and Growth Rate

    8 Europe Pharmaceutical CDMO Services Landscape Analysis

    • 8.1 Europe Pharmaceutical CDMO Services Landscape Analysis by Major Types

    • 8.2 Europe Pharmaceutical CDMO Services Landscape Analysis by Major End-Users

    • 8.3 Europe Pharmaceutical CDMO Services Landscape Analysis by Major Countries

      • 8.3.1 Germany Pharmaceutical CDMO Services Market Volume and Growth Rate

      • 8.3.2 UK Pharmaceutical CDMO Services Market Volume and Growth Rate

      • 8.3.3 France Pharmaceutical CDMO Services Market Volume and Growth Rate

      • 8.3.4 Italy Pharmaceutical CDMO Services Market Volume and Growth Rate

      • 8.3.5 Nordic Countries Pharmaceutical CDMO Services Market Volume and Growth Rate

      • 8.3.6 Spain Pharmaceutical CDMO Services Market Volume and Growth Rate

      • 8.3.7 Belgium Pharmaceutical CDMO Services Market Volume and Growth Rate

      • 8.3.8 Poland Pharmaceutical CDMO Services Market Volume and Growth Rate

      • 8.3.9 Russia Pharmaceutical CDMO Services Market Volume and Growth Rate

      • 8.3.10 Turkey Pharmaceutical CDMO Services Market Volume and Growth Rate

    9 Asia Pacific Pharmaceutical CDMO Services Landscape Analysis

    • 9.1 Asia Pacific Pharmaceutical CDMO Services Landscape Analysis by Major Types

    • 9.2 Asia Pacific Pharmaceutical CDMO Services Landscape Analysis by Major End-Users

    • 9.3 Asia Pacific Pharmaceutical CDMO Services Landscape Analysis by Major Countries

      • 9.3.1 China Pharmaceutical CDMO Services Market Volume and Growth Rate

      • 9.3.2 Japan Pharmaceutical CDMO Services Market Volume and Growth Rate

      • 9.3.3 Australia and New Zealand Pharmaceutical CDMO Services Market Volume and Growth Rate

      • 9.3.4 India Pharmaceutical CDMO Services Market Volume and Growth Rate

      • 9.3.5 ASEAN Countries Pharmaceutical CDMO Services Market Volume and Growth Rate

      • 9.3.6 South Korea Pharmaceutical CDMO Services Market Volume and Growth Rate

    10 Latin America, Middle East & Africa Pharmaceutical CDMO Services Landscape Analysis

    • 10.1 Latin America, Middle East & Africa Pharmaceutical CDMO Services Landscape Analysis by Major Types

    • 10.2 Latin America, Middle East & Africa Pharmaceutical CDMO Services Landscape Analysis by Major End-Users

    • 10.3 Latin America, Middle East & Africa Pharmaceutical CDMO Services Landscape Analysis by Major Countries

      • 10.3.1 GCC Countries Pharmaceutical CDMO Services Market Volume and Growth Rate

      • 10.3.2 Brazil Pharmaceutical CDMO Services Market Volume and Growth Rate

      • 10.3.3 Nigeria Pharmaceutical CDMO Services Market Volume and Growth Rate

      • 10.3.4 South Africa Pharmaceutical CDMO Services Market Volume and Growth Rate 

      • 10.3.5 Argentina Pharmaceutical CDMO Services Market Volume and Growth Rate

    11 Major Players Profile

    • 11.1 Amatsigroup

      • 11.1.1 Amatsigroup Company Profile and Recent Development

      • 11.1.2 Market Performance

      • 11.1.3 Product and Service Introduction

    • 11.2 FAMAR Health Care Services

      • 11.2.1 FAMAR Health Care Services Company Profile and Recent Development

      • 11.2.2 Market Performance

      • 11.2.3 Product and Service Introduction

    • 11.3 Piramal Pharma Solutions

      • 11.3.1 Piramal Pharma Solutions Company Profile and Recent Development

      • 11.3.2 Market Performance

      • 11.3.3 Product and Service Introduction

    • 11.4 Strides Pharma Science Limited

      • 11.4.1 Strides Pharma Science Limited Company Profile and Recent Development

      • 11.4.2 Market Performance

      • 11.4.3 Product and Service Introduction

    • 11.5 Fareva Group

      • 11.5.1 Fareva Group Company Profile and Recent Development

      • 11.5.2 Market Performance

      • 11.5.3 Product and Service Introduction

    • 11.6 Aenova Group

      • 11.6.1 Aenova Group Company Profile and Recent Development

      • 11.6.2 Market Performance

      • 11.6.3 Product and Service Introduction

    • 11.7 WuXi AppTec Group

      • 11.7.1 WuXi AppTec Group Company Profile and Recent Development

      • 11.7.2 Market Performance

      • 11.7.3 Product and Service Introduction

    • 11.8 AMRI Global

      • 11.8.1 AMRI Global Company Profile and Recent Development

      • 11.8.2 Market Performance

      • 11.8.3 Product and Service Introduction

    • 11.9 Siegfried Ltd

      • 11.9.1 Siegfried Ltd Company Profile and Recent Development

      • 11.9.2 Market Performance

      • 11.9.3 Product and Service Introduction

    • 11.10 Patheon NV

      • 11.10.1 Patheon NV Company Profile and Recent Development

      • 11.10.2 Market Performance

      • 11.10.3 Product and Service Introduction

    • 11.11 Recipharm AB

      • 11.11.1 Recipharm AB Company Profile and Recent Development

      • 11.11.2 Market Performance

      • 11.11.3 Product and Service Introduction

    • 11.12 Catalent, Inc

      • 11.12.1 Catalent, Inc Company Profile and Recent Development

      • 11.12.2 Market Performance

      • 11.12.3 Product and Service Introduction

    12 Data Source and Research Methodology

    The List of Tables and Figures (Totals 119 Figures and 141 Tables)

    • Figure Product Picture

    • Figure Pharmaceutical CDMO Services Market Size and Growth Rate of Drug Substance Development and Manufacturing from 2014 to 2026

    • Figure Pharmaceutical CDMO Services Market Size and Growth Rate of Specialized Services from 2014 to 2026

    • Figure Pharmaceutical CDMO Services Market Size and Growth Rate of Lab-based Services from 2014 to 2026

    • Figure Market Share by Type in 2014

    • Figure Market Share by Type in 2018

    • Figure Market Share by Type in 2026

    • Figure Global Pharmaceutical CDMO Services Market Size and Growth Rate of Innovative Medicine from 2014 to 2026

    • Figure Global Pharmaceutical CDMO Services Market Size and Growth Rate of Patented Drug from 2014 to 2026

    • Figure Global Pharmaceutical CDMO Services Market Size and Growth Rate of Patent Expired Drug from 2014 to 2026

    • Figure Market Share by End-User in 2014

    • Figure Market Share by End-User in 2018

    • Figure Market Share by End-User in 2026

    • Figure North America Pharmaceutical CDMO Services Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure United States Pharmaceutical CDMO Services Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Pharmaceutical CDMO Services Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Pharmaceutical CDMO Services Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Europe Pharmaceutical CDMO Services Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Germany Pharmaceutical CDMO Services Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure UK Pharmaceutical CDMO Services Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure France Pharmaceutical CDMO Services Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Pharmaceutical CDMO Services Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries Pharmaceutical CDMO Services Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Pharmaceutical CDMO Services Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Pharmaceutical CDMO Services Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Pharmaceutical CDMO Services Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Pharmaceutical CDMO Services Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Pharmaceutical CDMO Services Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Asia-Pacific Pharmaceutical CDMO Services Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure China Pharmaceutical CDMO Services Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Japan Pharmaceutical CDMO Services Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Australia and New Zealand Pharmaceutical CDMO Services Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure India Pharmaceutical CDMO Services Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure ASEAN Countries Pharmaceutical CDMO Services Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure South Korea Pharmaceutical CDMO Services Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Latin America, Middle East & Africa Pharmaceutical CDMO Services Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure GCC Countries Pharmaceutical CDMO Services Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Brazil Pharmaceutical CDMO Services Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Nigeria Pharmaceutical CDMO Services Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure South Africa Pharmaceutical CDMO Services Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Argentina Pharmaceutical CDMO Services Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Pharmaceutical CDMO Services Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2018

    • Figure Market Share of TOP 5 Players in 2018

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Pharmaceutical CDMO Services

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Pharmaceutical CDMO Services by Different Types from 2014 to 2026

    • Table Consumption Share of Pharmaceutical CDMO Services by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Drug Substance Development and Manufacturing

    • Figure Market Size and Growth Rate of Specialized Services

    • Figure Market Size and Growth Rate of Lab-based Services

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Pharmaceutical CDMO Services by Different End-Users from 2014 to 2026

    • Table Consumption Share of Pharmaceutical CDMO Services by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Innovative Medicine

    • Figure Market Size and Growth Rate of Patented Drug

    • Figure Market Size and Growth Rate of Patent Expired Drug

    • Table Global Pharmaceutical CDMO Services Production by Major Regions

    • Table Global Pharmaceutical CDMO Services Production Share by Major Regions

    • Figure Global Pharmaceutical CDMO Services Production Share by Major Regions in 2014

    • Figure Global Pharmaceutical CDMO Services Production Share by Major Regions in 2018

    • Figure Global Pharmaceutical CDMO Services Production Share by Major Regions in 2026

    • Table Global Pharmaceutical CDMO Services Consumption by Major Regions

    • Table Global Pharmaceutical CDMO Services Consumption Share by Major Regions

    • Figure Global Pharmaceutical CDMO Services Consumption Share by Major Regions in 2014

    • Figure Global Pharmaceutical CDMO Services Consumption Share by Major Regions in 2018

    • Figure Global Pharmaceutical CDMO Services Consumption Share by Major Regions in 2026

    • Table North America Pharmaceutical CDMO Services Production, Import, Consumption and Export Analysis

    • Table Europe Pharmaceutical CDMO Services Production, Import, Consumption and Export Analysis

    • Table Asia Pacific Pharmaceutical CDMO Services Production, Import, Consumption and Export Analysis

    • Table Latin America, Middle East & Africa Pharmaceutical CDMO Services Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Pharmaceutical CDMO Services market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Pharmaceutical CDMO Services market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Pharmaceutical CDMO Services market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Pharmaceutical CDMO Services market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table North America Pharmaceutical CDMO Services Consumption by Types from 2014 to 2026

    • Table North America Pharmaceutical CDMO Services Consumption Share by Types from 2014 to 2026

    • Figure North America Pharmaceutical CDMO Services Consumption Share by Types in 2014

    • Figure North America Pharmaceutical CDMO Services Consumption Share by Types in 2018

    • Figure North America Pharmaceutical CDMO Services Consumption Share by Types in 2026

    • Table North America Pharmaceutical CDMO Services Consumption by End-Users from 2014 to 2026

    • Table North America Pharmaceutical CDMO Services Consumption Share by End-Users from 2014 to 2026

    • Figure North America Pharmaceutical CDMO Services Consumption Share by End-Users in 2014

    • Figure North America Pharmaceutical CDMO Services Consumption Share by End-Users in 2018

    • Figure North America Pharmaceutical CDMO Services Consumption Share by End-Users in 2026

    • Table North America Pharmaceutical CDMO Services Consumption by Major Countries from 2014 to 2026

    • Table North America Pharmaceutical CDMO Services Consumption Share by Major Countries from 2014 to 2026

    • Figure North America Pharmaceutical CDMO Services Consumption Share by Major Countries in 2014

    • Figure North America Pharmaceutical CDMO Services Consumption Share by Major Countries in 2018

    • Figure North America Pharmaceutical CDMO Services Consumption Share by Major Countries in 2026

    • Figure United States Pharmaceutical CDMO Services Market Volume and Growth Rate from 2014 to 2026

    • Figure Canada Pharmaceutical CDMO Services Market Volume and Growth Rate from 2014 to 2026

    • Figure Mexico Pharmaceutical CDMO Services Market Volume and Growth Rate from 2014 to 2026

    • Table Europe Pharmaceutical CDMO Services Consumption by Types from 2014 to 2026

    • Table Europe Pharmaceutical CDMO Services Consumption Share by Types from 2014 to 2026

    • Figure Europe Pharmaceutical CDMO Services Consumption Share by Types in 2014

    • Figure Europe Pharmaceutical CDMO Services Consumption Share by Types in 2018

    • Figure Europe Pharmaceutical CDMO Services Consumption Share by Types in 2026

    • Table Europe Pharmaceutical CDMO Services Consumption by End-Users from 2014 to 2026

    • Table Europe Pharmaceutical CDMO Services Consumption Share by End-Users from 2014 to 2026

    • Figure Europe Pharmaceutical CDMO Services Consumption Share by End-Users in 2014

    • Figure Europe Pharmaceutical CDMO Services Consumption Share by End-Users in 2018

    • Figure Europe Pharmaceutical CDMO Services Consumption Share by End-Users in 2026

    • Table Europe Pharmaceutical CDMO Services Consumption by Major Countries from 2014 to 2026

    • Table Europe Pharmaceutical CDMO Services Consumption Share by Major Countries from 2014 to 2026

    • Figure Europe Pharmaceutical CDMO Services Consumption Share by Major Countries in 2014

    • Figure Europe Pharmaceutical CDMO Services Consumption Share by Major Countries in 2018

    • Figure Europe Pharmaceutical CDMO Services Consumption Share by Major Countries in 2026

    • Figure Germany Pharmaceutical CDMO Services Market Volume and Growth Rate from 2014 to 2026

    • Figure UK Pharmaceutical CDMO Services Market Volume and Growth Rate from 2014 to 2026

    • Figure France Pharmaceutical CDMO Services Market Volume and Growth Rate from 2014 to 2026

    • Figure Italy Pharmaceutical CDMO Services Market Volume and Growth Rate from 2014 to 2026

    • Figure Nordic Countries Pharmaceutical CDMO Services Market Volume and Growth Rate from 2014 to 2026

    • Figure Belgium Pharmaceutical CDMO Services Market Volume and Growth Rate from 2014 to 2026

    • Figure Poland Pharmaceutical CDMO Services Market Volume and Growth Rate from 2014 to 2026

    • Figure Russia Pharmaceutical CDMO Services Market Volume and Growth Rate from 2014 to 2026

    • Figure Turkey Pharmaceutical CDMO Services Market Volume and Growth Rate from 2014 to 2026

    • Table Asia Pacific Pharmaceutical CDMO Services Consumption by Types from 2014 to 2026

    • Table Asia Pacific Pharmaceutical CDMO Services Consumption Share by Types from 2014 to 2026

    • Figure Asia Pacific Pharmaceutical CDMO Services Consumption Share by Types in 2014

    • Figure Asia Pacific Pharmaceutical CDMO Services Consumption Share by Types in 2018

    • Figure Asia Pacific Pharmaceutical CDMO Services Consumption Share by Types in 2026

    • Table Asia Pacific Pharmaceutical CDMO Services Consumption by End-Users from 2014 to 2026

    • Table Asia Pacific Pharmaceutical CDMO Services Consumption Share by End-Users from 2014 to 2026

    • Figure Asia Pacific Pharmaceutical CDMO Services Consumption Share by End-Users in 2014

    • Figure Asia Pacific Pharmaceutical CDMO Services Consumption Share by End-Users in 2018

    • Figure Asia Pacific Pharmaceutical CDMO Services Consumption Share by End-Users in 2026

    • Table Asia Pacific Pharmaceutical CDMO Services Consumption by Major Countries from 2014 to 2026

    • Table Asia Pacific Pharmaceutical CDMO Services Consumption Share by Major Countries from 2014 to 2026

    • Figure Asia Pacific Pharmaceutical CDMO Services Consumption Share by Major Countries in 2014

    • Figure Asia Pacific Pharmaceutical CDMO Services Consumption Share by Major Countries in 2018

    • Figure Asia Pacific Pharmaceutical CDMO Services Consumption Share by Major Countries in 2026

    • Figure China Pharmaceutical CDMO Services Market Volume and Growth Rate from 2014 to 2026

    • Figure Japan Pharmaceutical CDMO Services Market Volume and Growth Rate from 2014 to 2026

    • Figure Australia and New ZealandPharmaceutical CDMO Services Market Volume and Growth Rate from 2014 to 2026

    • Figure India Pharmaceutical CDMO Services Market Volume and Growth Rate from 2014 to 2026

    • Figure ASEAN Countries Pharmaceutical CDMO Services Market Volume and Growth Rate from 2014 to 2026

    • Figure South Korea Pharmaceutical CDMO Services Market Volume and Growth Rate from 2014 to 2026

    • Table Latin America, Middle East & Africa Pharmaceutical CDMO Services Consumption by Types from 2014 to 2026

    • Table Latin America, Middle East & Africa Pharmaceutical CDMO Services Consumption Share by Types from 2014 to 2026

    • Figure Latin America, Middle East & Africa Pharmaceutical CDMO Services Consumption Share by Types in 2014

    • Figure Latin America, Middle East & Africa Pharmaceutical CDMO Services Consumption Share by Types in 2018

    • Figure Latin America, Middle East & Africa Pharmaceutical CDMO Services Consumption Share by Types in 2026

    • Table Latin America, Middle East & Africa Pharmaceutical CDMO Services Consumption by End-Users from 2014 to 2026

    • Table Latin America, Middle East & Africa Pharmaceutical CDMO Services Consumption Share by End-Users from 2014 to 2026

    • Figure Latin America, Middle East & Africa Pharmaceutical CDMO Services Consumption Share by End-Users in 2014

    • Figure Latin America, Middle East & Africa Pharmaceutical CDMO Services Consumption Share by End-Users in 2018

    • Figure Latin America, Middle East & Africa Pharmaceutical CDMO Services Consumption Share by End-Users in 2026

    • Table Latin America, Middle East & Africa Pharmaceutical CDMO Services Consumption by Major Countries from 2014 to 2026

    • Table Latin America, Middle East & Africa Pharmaceutical CDMO Services Consumption Share by Major Countries from 2014 to 2026

    • Figure Latin America, Middle East & Africa Pharmaceutical CDMO Services Consumption Share by Major Countries in 2014

    • Figure Latin America, Middle East & Africa Pharmaceutical CDMO Services Consumption Share by Major Countries in 2018

    • Figure Latin America, Middle East & Africa Pharmaceutical CDMO Services Consumption Share by Major Countries in 2026

    • Figure GCC Countries Pharmaceutical CDMO Services Market Volume and Growth Rate from 2014 to 2026

    • Figure Brazil Pharmaceutical CDMO Services Market Volume and Growth Rate from 2014 to 2026

    • Figure Nigeria Pharmaceutical CDMO Services Market Volume and Growth Rate from 2014 to 2026

    • Figure South Africa Pharmaceutical CDMO Services Market Volume and Growth Rate from 2014 to 2026

    • Figure Argentina Pharmaceutical CDMO Services Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of Amatsigroup

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Amatsigroup

    • Figure Sales and Growth Rate Analysis of Amatsigroup

    • Figure Revenue and Market Share Analysis of Amatsigroup

    • Table Product and Service Introduction of Amatsigroup

    • Table Company Profile and Development Status of FAMAR Health Care Services

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of FAMAR Health Care Services

    • Figure Sales and Growth Rate Analysis of FAMAR Health Care Services

    • Figure Revenue and Market Share Analysis of FAMAR Health Care Services

    • Table Product and Service Introduction of FAMAR Health Care Services

    • Table Company Profile and Development Status of Piramal Pharma Solutions

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Piramal Pharma Solutions

    • Figure Sales and Growth Rate Analysis of Piramal Pharma Solutions

    • Figure Revenue and Market Share Analysis of Piramal Pharma Solutions

    • Table Product and Service Introduction of Piramal Pharma Solutions

    • Table Company Profile and Development Status of Strides Pharma Science Limited

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Strides Pharma Science Limited

    • Figure Sales and Growth Rate Analysis of Strides Pharma Science Limited

    • Figure Revenue and Market Share Analysis of Strides Pharma Science Limited

    • Table Product and Service Introduction of Strides Pharma Science Limited

    • Table Company Profile and Development Status of Fareva Group

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Fareva Group

    • Figure Sales and Growth Rate Analysis of Fareva Group

    • Figure Revenue and Market Share Analysis of Fareva Group

    • Table Product and Service Introduction of Fareva Group

    • Table Company Profile and Development Status of Aenova Group

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Aenova Group

    • Figure Sales and Growth Rate Analysis of Aenova Group

    • Figure Revenue and Market Share Analysis of Aenova Group

    • Table Product and Service Introduction of Aenova Group

    • Table Company Profile and Development Status of WuXi AppTec Group

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of WuXi AppTec Group

    • Figure Sales and Growth Rate Analysis of WuXi AppTec Group

    • Figure Revenue and Market Share Analysis of WuXi AppTec Group

    • Table Product and Service Introduction of WuXi AppTec Group

    • Table Company Profile and Development Status of AMRI Global

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AMRI Global

    • Figure Sales and Growth Rate Analysis of AMRI Global

    • Figure Revenue and Market Share Analysis of AMRI Global

    • Table Product and Service Introduction of AMRI Global

    • Table Company Profile and Development Status of Siegfried Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Siegfried Ltd

    • Figure Sales and Growth Rate Analysis of Siegfried Ltd

    • Figure Revenue and Market Share Analysis of Siegfried Ltd

    • Table Product and Service Introduction of Siegfried Ltd

    • Table Company Profile and Development Status of Patheon NV

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Patheon NV

    • Figure Sales and Growth Rate Analysis of Patheon NV

    • Figure Revenue and Market Share Analysis of Patheon NV

    • Table Product and Service Introduction of Patheon NV

    • Table Company Profile and Development Status of Recipharm AB

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Recipharm AB

    • Figure Sales and Growth Rate Analysis of Recipharm AB

    • Figure Revenue and Market Share Analysis of Recipharm AB

    • Table Product and Service Introduction of Recipharm AB

    • Table Company Profile and Development Status of Catalent, Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Catalent, Inc

    • Figure Sales and Growth Rate Analysis of Catalent, Inc

    • Figure Revenue and Market Share Analysis of Catalent, Inc

    • Table Product and Service Introduction of Catalent, Inc


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.